187 related articles for article (PubMed ID: 32801002)
1. Biological evaluation and molecular modeling of peptidomimetic compounds as inhibitors for O-GlcNAc transferase (OGT).
Albuquerque SO; Barros TG; Dias LRS; Lima CHDS; Azevedo PHRA; Flores-Junior LAP; Dos Santos EG; Loponte HF; Pinheiro S; Dias WB; Muri EMF; Todeschini AR
Eur J Pharm Sci; 2020 Nov; 154():105510. PubMed ID: 32801002
[TBL] [Abstract][Full Text] [Related]
2. Mutations in
Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
[No Abstract] [Full Text] [Related]
3. O-GlcNAc transferase inhibitors: current tools and future challenges.
Trapannone R; Rafie K; van Aalten DM
Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
[TBL] [Abstract][Full Text] [Related]
4. New ELISA-based method for the detection of O-GlcNAc transferase activity in vitro.
Qi J; Wang R; Zeng Y; Yu W; Gu Y
Prep Biochem Biotechnol; 2017 Aug; 47(7):699-702. PubMed ID: 28296566
[TBL] [Abstract][Full Text] [Related]
5. Bisubstrate Ether-Linked Uridine-Peptide Conjugates as O-GlcNAc Transferase Inhibitors.
Makwana V; Ryan P; Malde AK; Anoopkumar-Dukie S; Rudrawar S
ChemMedChem; 2021 Feb; 16(3):477-483. PubMed ID: 32991074
[TBL] [Abstract][Full Text] [Related]
6. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
Ryan P; Shi Y; von Itzstein M; Rudrawar S
Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of
Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
[TBL] [Abstract][Full Text] [Related]
8. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
[TBL] [Abstract][Full Text] [Related]
9. O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
Ono S; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Chin-Kanasaki M; Araki H; Sekine O; Yokoi H; Mukoyama M; Uzu T; Araki SI; Maegawa H
Nephrol Dial Transplant; 2017 Sep; 32(9):1477-1487. PubMed ID: 28339907
[TBL] [Abstract][Full Text] [Related]
10. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
11. Engineering a Proximity-Directed O-GlcNAc Transferase for Selective Protein O-GlcNAcylation in Cells.
Ramirez DH; Aonbangkhen C; Wu HY; Naftaly JA; Tang S; O'Meara TR; Woo CM
ACS Chem Biol; 2020 Apr; 15(4):1059-1066. PubMed ID: 32119511
[TBL] [Abstract][Full Text] [Related]
12. OGT: a short overview of an enzyme standing out from usual glycosyltransferases.
Aquino-Gil M; Pierce A; Perez-Cervera Y; Zenteno E; Lefebvre T
Biochem Soc Trans; 2017 Apr; 45(2):365-370. PubMed ID: 28408476
[No Abstract] [Full Text] [Related]
13. Overview of the Assays to Probe
Balsollier C; Pieters RJ; Anderluh M
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669256
[No Abstract] [Full Text] [Related]
14. Ac
Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
[TBL] [Abstract][Full Text] [Related]
15. Intracellular Hydrolysis of Small-Molecule
Loi EM; Weiss M; Pajk S; Gobec M; Tomašič T; Pieters RJ; Anderluh M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32722493
[No Abstract] [Full Text] [Related]
16. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
17. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
18. Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity.
Iyer SP; Hart GW
J Biol Chem; 2003 Jul; 278(27):24608-16. PubMed ID: 12724313
[TBL] [Abstract][Full Text] [Related]
19. New Quinolinone O-GlcNAc Transferase Inhibitors Based on Fragment Growth.
Weiss M; Loi EM; Sterle M; Balsollier C; Tomašič T; Pieters RJ; Gobec M; Anderluh M
Front Chem; 2021; 9():666122. PubMed ID: 33937202
[TBL] [Abstract][Full Text] [Related]
20. Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim EJ; Abramowitz LK; Bond MR; Love DC; Kang DW; Leucke HF; Kang DW; Ahn JS; Hanover JA
Bioconjug Chem; 2014 Jun; 25(6):1025-30. PubMed ID: 24866374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
